Advertisement
At close: 04:00PM EST
After hours:
| Previous Close | 155.17 |
| Open | 155.17 |
| Bid | 155.71 x 1000 |
| Ask | 155.64 x 900 |
| Day's Range | 155.14 - 157.01 |
| 52 Week Range | 143.13 - 168.85 |
| Volume | |
| Avg. Volume | 6,418,146 |
| Market Cap | 375.059B |
| Beta (5Y Monthly) | 0.52 |
| PE Ratio (TTM) | 25.75 |
| EPS (TTM) | 6.05 |
| Earnings Date | Jan 22, 2025 |
| Forward Dividend & Yield | 4.96 (3.20%) |
| Ex-Dividend Date | Nov 26, 2024 |
| 1y Target Est | 174.89 |
ZacksJ&J Seeks FDA Nod for Subcutaneous Tremfya as Induction Regimen in UC
If approved, JNJ's Tremfya will be the first IL-23 inhibitor to offer a choice of subcutaneous or intravenous use as induction treatment in ulcerative colitis.
Insider MonkeyHedge Funds Bet Big On Johnson & Johnson (JNJ): Top Healthcare Stock to Watch
We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other most promising healthcare stocks according to hedge funds. The Healthcare Sector: Growth, Innovation, and the Impact of AI The healthcare sector […]
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.